This study systematically elucidates the molecular regulatory role of CHI3L1 in RA and its close association with disease activity, while also confirming its diagnostic and prognostic potential through multilayered bioinformatics analyses and clinical validation. This evidence concerns the gene CHI3L1 and rheumatoid arthritis.